Dernières nouvelles

Information non disponible

Peretz Soroka H, Vora T, Noujaim J, Marcoux N, Cohen-Gogo S, Alcindor T, Holloway C, Rodrigues C, Karachiwala H, Alvi S, Lee U, Cheng S, Banerji S, Oberoi S, Feng X, Smrke A, Simmons C, Razak AA, Gupta AA

Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study

Article de revue

Cancer Med, 12 (18), 2023.

Résumé | Liens:

Rioux AV, Bergeron NA, Riopel J, Marcoux N, Thériault C, Gould PV, Garneau AP, Isenring P

The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications

Article de revue

J Mol Med (Berl), 101 (10), 2023.

Résumé | Liens:

El Yamani N, Cote G, Riopel J, Marcoux N, Mac-Way F, Philibert D, Agharazii M

Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case Report

Article de revue

Kidney Med, 5 (8), 2023.

Résumé | Liens:

Signaler des ajouts ou des modifications